OmniaBio
Jenifer Wheat is a seasoned professional in the biopharmaceutical industry, with extensive experience in commercial development and business leadership roles. Currently serving as the Chief Commercial Officer at OmniaBio, Jenifer has previously held similar positions at companies such as Solvias, Lykan Bioscience, Lonza, and Samsung BioLogics. With a strong background in global business development and commercial operations, Jenifer has continuously contributed to the growth and success of various organizations in the biotech sector. Jenifer's educational background includes degrees from UC San Diego, University of California Berkeley, San Francisco State University, and UNC Kenan-Flagler Business School.
This person is not in any teams
This person is not in any offices
OmniaBio
OmniaBio Inc., a subsidiary of CCRM, launched July 1, 2022. OmniaBio is a contract development and manufacturing organization (CDMO) conducting process development and producing gene-modified cells and viral vectors for Phase I clinical trials to commercial-scale manufacturing. OmniaBio is bringing life-saving cell and gene therapies to patients in Canada and around the world.